|
Tables available for Week 05, 2019 |
|
Table1a |
Anthrax; Arboviral diseases, neuroinvasive and non-neuroinvasive |
(Export Data) |
(PDF) |
Table1b |
Arboviral diseases, neuroinvasive and non-neuroinvasive (continued) |
(Export Data) |
(PDF) |
Table1c |
Arboviral diseases, neuroinvasive and non-neuroinvasive (continued) |
(Export Data) |
(PDF) |
Table1d |
Arboviral diseases, neuroinvasive and non-neuroinvasive (continued); Babesiosis |
(Export Data) |
(PDF) |
Table1e |
Botulism |
(Export Data) |
(PDF) |
Table1f |
Brucellosis; Campylobacteriosis; Candida auris, clinical |
(Export Data) |
(PDF) |
Table1g |
Carbapenemase-producing carbapenem-resistant Enterobacteriaceae; Chlamydia trachomatis infection; Chancroid |
(Export Data) |
(PDF) |
Table1h |
Cholera; Coccidioidomycosis |
(Export Data) |
(PDF) |
Table1i |
Cryptosporidiosis; Cyclosporiasis |
(Export Data) |
(PDF) |
Table1j |
Dengue virus infections |
(Export Data) |
(PDF) |
Table1k |
Ehrlichiosis and Anaplasmosis |
(Export Data) |
(PDF) |
Table1l |
Ehrlichiosis and Anaplasmosis (continued); Giardiasis |
(Export Data) |
(PDF) |
Table1m |
Gonorrhea; Haemophilus influenzae, invasive disease (all ages, all serotypes); Haemophilus influenzae, invasive disease (age <5 years) |
(Export Data) |
(PDF) |
Table1n |
Haemophilus influenzae, invasive disease, (age <5 years) (continued) |
(Export Data) |
(PDF) |
Table1o |
Hansen's disease; Hantavirus infection, non-hantavirus pulmonary syndrome; Hantavirus pulmonary syndrome |
(Export Data) |
(PDF) |
Table1p |
Hemolytic uremic syndrome post-diarrheal; Hepatitis (viral, acute, by type) |
(Export Data) |
(PDF) |
Table1q |
Hepatitis B, perinatal infection; Hepatitis C (viral, acute) |
(Export Data) |
(PDF) |
Table1r |
Hepatitis C, perinatal infection; Influenza-associated pediatric mortality |
(Export Data) |
(PDF) |
Table1s |
Invasive pneumococcal disease, all ages |
(Export Data) |
(PDF) |
Table1t |
Invasive pneumococcal disease, age <5 |
(Export Data) |
(PDF) |
Table1u |
Legionellosis; Leptospirosis; Listeriosis |
(Export Data) |
(PDF) |
Table1v |
Malaria; Measles |
(Export Data) |
(PDF) |
Table1w |
Meningococcal disease |
(Export Data) |
(PDF) |
Table1x |
Meningococcal disease (continued) |
(Export Data) |
(PDF) |
Table1y |
Mumps; Novel influenza A virus infections |
(Export Data) |
(PDF) |
Table1z |
Pertussis; Plague; Poliomyelitis, paralytic |
(Export Data) |
(PDF) |
Table1aa |
Poliovirus infection, nonparalytic; Psittacosis |
(Export Data) |
(PDF) |
Table1bb |
Q fever |
(Export Data) |
(PDF) |
Table1cc |
Rabies |
(Export Data) |
(PDF) |
Table1dd |
Rubella; Rubella, congenital syndrome |
(Export Data) |
(PDF) |
Table1ee |
Salmonella Paratyphi infection; Salmonella Typhi infection; Salmonellosis (excluding Salmonella Typhi infection and Salmonella Paratyphi infection) |
(Export Data) |
(PDF) |
Table1ff |
Severe acute respiratory syndrome-associated coronavirus disease; Shiga toxin-producing Escherichia coli; Shigellosis |
(Export Data) |
(PDF) |
Table1gg |
Spotted fever rickettsiosis; Smallpox |
(Export Data) |
(PDF) |
Table1hh |
Streptococcal toxic shock syndrome; Syphilis |
(Export Data) |
(PDF) |
Table1ii |
Tetanus; Toxic shock syndrome (other than streptococcal); Trichinellosis |
(Export Data) |
(PDF) |
Table1jj |
Tularemia; Vancomycin-intermediate Staphylococcus aureus |
(Export Data) |
(PDF) |
Table1kk |
Vancomycin-resistant Staphylococcus aureus; Varicella morbidity |
(Export Data) |
(PDF) |
Table1ll |
Vibriosis (any species of the family Vibrionaceae, other than toxigenic Vibrio cholerae O1 or O139) |
(Export Data) |
(PDF) |
Table1mm |
Viral hemorrhagic fevers |
(Export Data) |
(PDF) |
Table1nn |
Viral hemorrhagic fevers (continued) |
(Export Data) |
(PDF) |
Table1oo |
Viral hemorrhagic fevers (continued) |
(Export Data) |
(PDF) |
Table1pp |
Yellow fever; Zika virus disease, non-congenital |
(Export Data) |
(PDF) |
Table2 |
Tuberculosis |
(Export Data) |
(PDF) |
Figure 1 |
Figure 1 |
(n/a) |
(PDF) |